The current boom in AI infrastructure investment has entered a critical phase of divergence. Against this backdrop, significant capital is fleeing overvalued tech stocks and pouring into defensive sectors such as healthcare, where weightings are at historic lows, reflecting a shift in investor preference from chasing high growth to seeking quality assets with stable cash flows. The AI narrative is transitioning from “who is investing the most” to “who can most effectively translate investment into sustainable returns.”
Sarat Sethi, managing partner at U.S.-based independent asset management firm DCLA, has issued a clear warning: this “spending race” is spiraling out of control, and most participants will struggle to justify it to investors. Sethi noted that, apart from Alphabet (GOOGL), he holds growing concerns over the massive AI capital expenditure plans of other tech companies. Meanwhile, two key trends reshaping the market landscape have already emerged: hardware spending is “eating into” software budgets, and capital is flowing from high-valued tech stocks to defensive sectors like healthcare, which offer stable cash flows.
Sethi acknowledged that, despite his cautious stance on industry-wide spending, Alphabet remains a core holding in his portfolio. He believes Alphabet’s diversified business matrix—including YouTube, cloud services, and Gemini—offers flexible adjustment levers, allowing the company to adapt nimbly if AI investment returns fall short of expectations. This flexibility is a key differentiator setting Alphabet apart from other big AI spenders.
This assessment is evident in Alphabet’s second-quarter earnings. The company posted revenue of $119.8 billion, up 24% year-over-year, while Google Cloud revenue surged 82% to $24.8 billion. However, the market did not cheer, and the stock price fell instead, with the core pressure stemming from a startling spike in capital expenditure. The company’s second-quarter capex doubled year-over-year to $44.9 billion, and free cash flow turned negative for the first time in decades. The company also raised its full-year capex guidance to $195 billion–$205 billion and expects spending to remain significantly elevated through 2027.
Beyond the tech sector, Sethi highlighted the trend of capital rotating back into healthcare, citing companies such as Stryker (SYK), Thermo Fisher (TMO), and Johnson & Johnson (JNJ), which boast strong balance sheets and solid earnings growth. Healthcare’s current weighting in the S&P 500 has fallen to just 8.3%, the lowest since 1994, and has declined approximately 50% since 2022. Historical data show that when the sector hit a similarly low weighting in 2011, it outperformed the broader market by over 70 percentage points over the following four years.
Capital flows corroborate this trend. In the week ending early July, approximately $1.47 billion flowed into the healthcare sector. Over the past month, the healthcare ETF (XLV) attracted about $800 million in net inflows, while the tech ETF (XLK) experienced $8.7 billion in outflows—the highest among all S&P 500 sectors. Amid market turbulence, healthcare, consumer staples, and other defensive directions have moved countercyclically higher, offering opportunities for investors seeking stability and quality over momentum.
